AccScience Publishing / IMO / Online First / DOI: 10.36922/IMO026220029
Submit to IMO
Cite this article
4
Download
79
Views
Related Info Links
Google Scholar
More by Authors Links
Ilker S. Bayer
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Antibacterial emulsion based on methyl cellulose and lavender essential oil: Rheology and drug release kinetics

Gözde Bayer1 ,  Amirreza Shayganpour2 ,  Ilker S. Bayer3*
Show Less
1 Gempa Electromechanical Engineering Ltd. Co., Çankaya, Ankara, Türkiye
2 Smart Materials, Italian Institute of Technology, Genova, Liguria, Italy
3 I2Pure Corporation, Ashburn, Virginia, United States of America
IMO, 026220029 https://doi.org/10.36922/IMO026220029
Received: 27 May 2026 | Revised: 20 June 2026 | Accepted: 22 June 2026 | Published online: 30 July 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
XML
Cite
Abstract

Topical antibacterial emulsions require optimized formulation strategies to maximize drug release, bioavailability, and antimicrobial efficacy while maintaining desirable rheological properties. This study presents the formulation and characterization of an antibacterial emulsion comprising methyl cellulose, triacetin, triethyl citrate, and a synergistic blend of benzyl alcohol, phenylethanol, and lavender essential oil, designed for topical drug delivery. Emulsions were prepared by shear mixing and ultrasonic processing and evaluated for rheological behavior, essential oil release kinetics, and antimicrobial efficacy. Mechanical mixing physically disrupts macromolecular matrix entanglements, accelerating the dispersion of essential oils and significantly enhancing active terpene bioavailability, thereby driving rapid bactericidal kinetics. Viscoelastic and shear-thinning properties were modeled using Maxwell, Cross, and Herschel–Bulkley frameworks incorporating thixotropic considerations, revealing a yield stress of 8 Pa and strong structural recovery behavior. Ultraviolet–Visible spectrophotometry-based drug release studies demonstrated that shear mixing significantly enhanced essential oil release rates, with the Weibull model providing the best fit to the release profiles. Antibacterial testing against Escherichia coli and ten genetically diverse strains of lactic acid bacteria showed that aromatic alcohol-containing formulations significantly reduced minimum inhibitory concentration and minimum bactericidal concentration values, confirming synergistic antibacterial action. Optical density monitoring and bacterial viability modeling revealed substantially improved bactericidal activity under mixing conditions, attributed to enhanced dispersion and bioavailability of the essential oil. These results demonstrate that the formulation method plays a decisive role in both physical and antimicrobial performance, supporting the potential of these emulsions for treating skin infections and limiting the spread of antibiotic-resistant bacteria.

Graphical abstract
Keywords
Antibacterial
Emulsion
Essential oil
Methyl cellulose
Drug release
Viscoelasticity
Funding
This study is supported by Gempa Electromechanical Engineering Ltd. Co.
Conflict of interest
Gözde Bayer is an employee of Gempa Electromechanical Engineering Ltd. Co., which provided funding for this study. The remaining authors declare no competing interests.
References
  1. Qu F, Geng R, Liu Y, Zhu J. Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics. 2022;12(7):3372-3406. doi: 10.7150/thno.69999
  2. Yukuyama MN, Kato ET, Lobenberg R, Bou-Chacra N. Challenges and future prospects of nanoemulsion as a drug delivery system. Curr Pharm Des. 2017;23(3):495-508. doi: 10.2174/1381612822666161027111957
  3. Charman SA, Charman WN, Rogge MC, Wilson DT, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992;9(1):87-93. doi: 10.1023/A:1018987928936
  4. Rodriguez J, Martín MJ, Ruiz MJG, Clares B. Current encapsulation strategies for bioactive oils: from alimentary to pharmaceutical perspectives. Food Res Int. 2016;83:41-59. doi: 10.1016/j.foodres.2016.01.032
  5. Stefanov SR, Andonova VY. Lipid nanoparticulate drug delivery systems: recent advances in the treatment of skin disorders. Pharmaceuticals. 2021;14(11):1083. doi: 10.3390/ph14111083
  6. Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: a review. Biomater Res. 2021;25(1):24. doi: 10.1186/s40824-021-00226-6
  7. Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS Omega. 2023;8(22):19145-19167. doi: 10.1021/acsomega.2c08016
  8. Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12(9):855. doi: 10.3390/pharmaceutics12090855
  9. Tran M, Wang C. Semi-solid materials for controlled release drug formulation: current status and future prospects. Front Chem Sci Eng. 2014;8(2):225-232. doi: 10.1007/s11705-014-1429-7
  10. Zhang H, Pan Y, Hou Y, Li M, Deng J, Wang B, Hao S. Smart physical-based transdermal drug delivery system: towards intelligence and controlled release. Small. 2024;20(9):e2306944. doi: 10.1002/smll.202306944
  11. Bushi E, Malaj L, Di Martino P, Mataj G, Myftari B. Formulation of semi solid dosage forms for topical application utilizing quality by design (QbD) approach. Drug Dev Ind Pharm. 2025;51(7):670-678. doi: 10.1080/03639045.2025.2498521
  12. Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309(1-2):44-50. doi: 10.1016/j.ijpharm.2005.10.044
  13. Kosmidis K, Argyrakis P, Macheras P. A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function. Pharm Res. 2003;20(7):988-995. doi: 10.1023/A:1024497920145
  14. Corsaro C, Neri G, Mezzasalma MAM, Fazio E. Weibull modeling of controlled drug release from Ag-PMA nanosystems. Polymers. 2021;13(17):2897. doi: 10.3390/polym13172897
  15. Chaves CRS, Salamandane A, Vieira EJF, Salamandane C. Antibiotic resistance in fermented foods chain: evaluating the risks of emergence of enterococci as an emerging pathogen in raw milk cheese. Int J Microbiol. 2024;2024(1):2409270. doi: 10.1155/ijm/2409270
  16. Nawaz M, Wang J, Zhou A, Ma C, Ma C, Wu X, Moore J, Millar BC, Xu J. Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products. Curr Microbiol. 2011;62(3):1081-1089. doi: 10.1007/s00284-010-9856-2
  17. Floris I, Battistini R, Tramuta C, Garcia-Vozmediano A, Musolino N, Scardino G, Masotti C, Brusa B, Orusa R, Serracca L, et al. Antibiotic resistance in lactic acid bacteria from dairy products in Northern Italy. Antibiotics. 2025;14(4):375. doi: 10.3390/antibiotics14040375
  18. Jian Z, Zeng L, Xu T, Sun S, Yan S, Yang L, Huang Y, Jia J, Dou T. Antibiotic resistance genes in bacteria: occurrence, spread, and control. J Basic Microbiol. 2021;61(12):1049-1070. doi: 10.1002/jobm.202100201
  19. Anisimova E, Yarullina D. Antibiotic resistance of Lactobacillus strains. Curr Microbiol. 2019;76(12):1407-1416. doi: 10.1007/s00284-019-01769-7
  20. Yusupova U, Tojiboeva D, Mukhamatkhanova R, Dusmatova D. Essential oils as an alternative to synthetic antiseptics in cosmetics and personal care products. Chem Biodivers. 2026;23(1):e03449. doi: 10.1002/cbdv.202503449
  21. Wells R, Truong F, Adal AM, Sarker LS, Mahmoud SS. Lavandula essential oils: a current review of applications in medicinal, food, and cosmetic industries of lavender. Nat Prod Commun. 2018;13(10). doi: 10.1177/1934578X1801301038
  22. Samuelson R, Lobl M, Higgins S, Clarey D, Wysong A. The effects of lavender essential oil on wound healing: a review of the current evidence. J Altern Complement Med. 2020;26(8):680-690. doi: 10.1089/acm.2019.0286
  23. Zuzarte M, Gonçalves M, Cavaleiro C, Canhoto J, Vale-Silva L, Silva M, Pinto E, Salgueiro L. Chemical composition and antifungal activity of the essential oils of Lavandula viridis from Portugal. J Med Microbiol. 2011;60(5):612-618. doi: 10.1099/jmm.0.027748-0
  24. Garcia CR, Malik MH, Biswas S, Tam VH, Rumbaugh KP, Li W, Liu X. Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils. Biomater Sci. 2022;10(3):633-653. doi: 10.1039/D1BM01537K
  25. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils: a review. Food Chem Toxicol. 2008;46(2):446-475. doi: 10.1016/j.fct.2007.09.106
  26. Nunziata L, Brasca M, Morandi S, Silvetti T. Antibiotic resistance in wild and commercial non-enterococcal lactic acid bacteria and bifidobacteria strains of dairy origin: an update. Food Microbiol. 2022;104:103999. doi: 10.1016/j.fm.2022.103999
  27. Botina SG, Poluektova E, Glazova A, Zakharevich NV, Koroban N, Zinchenko V, Babykin M, Zhilenkova O, Amerkhanova A, et al. Antibiotic resistance of potential probiotic bacteria of the genus Lactobacillus from human gastrointestinal microbiome. Microbiology. 2011;80(2):164-171. doi: 10.1134/S0026261711020032
  28. Toomey N, Monaghan A, Fanning S, Bolton D. Transfer of antibiotic resistance marker genes between lactic acid bacteria in model rumen and plant environments. Appl Environ Microbiol. 2009;75(10):3146-3152. doi: 10.1128/AEM.02471-08
  29. Gad GF, Abdel-Hamid AM, Farag ZS. Antibiotic resistance in lactic acid bacteria isolated from some pharmaceutical and dairy products. Braz J Microbiol. 2014;45(1):25-33. doi: 10.1590/S1517-83822014000100005
  30. Samtiya M, Matthews KR, Dhewa T, Puniya AK. Antimicrobial resistance in the food chain: trends, mechanisms, pathways, and possible regulation strategies. Foods. 2022;11(19):2966. doi: 10.3390/foods11192966
  31. Tadros TF. Emulsion formation, stability, and rheology. In: Emulsion Formation and Stability. Wiley; 2013:1-75. doi: 10.1002/9783527647941.ch1
  32. Wu X, Xue H, Bordia G, Fink Z, Kim PY, Streubel R, Han J, Helms BA, Ashby PD, Omar AK, Russell TP. Self-propulsion by directed explosive emulsification. Adv Mater. 2024;36(19):2310435. doi: 10.1002/adma.202310435
  33. Forgiarini A, Esquena J, González C, Solans C. Formation of nano-emulsions by low-energy emulsification methods at constant temperature. Langmuir. 2001;17(7):2076-2083. doi: 10.1021/LA001362N
  34. Dabbaghi M, Namjoshi S, Panchal B, Grice J, Prakash S, Roberts M, Mohammed YH. Viscoelastic and deformation characteristics of structurally different commercial topical systems. Pharmaceutics. 2021;13(9):1351. doi: 10.3390/pharmaceutics13091351
  35. Herbig ME, Evers DH, Gorissen S, Köllmer M. Rational design of topical semi-solid dosage forms—how far are we? Pharmaceutics. 2023;15(7):1822. doi: 10.3390/pharmaceutics15071822
  36. Salim N, Ahmad N, Musa SH, Hashim R, Tadros TF, Basri M. Nanoemulsion as a topical delivery system of antipsoriatic drugs. RSC Adv. 2016;6(8):6234-6250. doi: 10.1039/C5RA14946K
  37. McClements DJ. Food Emulsions: Principles, Practices, and Techniques. 2nd ed. CRC Press; 2004. doi: 10.1201/9781420039436
  38. Walstra P. Physical Chemistry of Foods. CRC Press; 2001. doi: 10.1201/9780203910436
  39. Karasulu HY. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity. Expert Opin Drug Deliv. 2008;5(1):119-135. doi: 10.1517/17425247.5.1.119
  40. Villay A, De Filippis F, Picton L, Cerf D, Vial C, Michaud P. Comparison of polysaccharide degradations by dynamic high-pressure homogenization. Food Hydrocoll. 2012;27(2):278-286. doi: 10.1016/J.FOODHYD.2011.10.003
  41. Qayum A, Rashid A, Liang Q, Wu Y, Cheng Y, Kang L, Liu Y, Zhou C, Hussain M, Ren X, et al. Ultrasonic and homogenization: an overview of the preparation of an edible protein–polysaccharide complex emulsion. Compr Rev Food Sci Food Saf. 2023;22(6):4242-4281. doi: 10.1111/1541-4337.13221
  42. Kumbhar P, Desai H, Desai V, Priya S, Rana V, Singhvi G. Versatility of emulgel in topical drug delivery: transforming its expedition from bench to bedside. Expert Opin Drug Deliv. 2025;22(1):55-68. doi: 10.1080/17425247.2024.2439457
  43. Ojha B, Jain VK, Gupta S, Talegaonkar S, Jain K. Nanoemulgel: a promising novel formulation for treatment of skin ailments. Polym Bull. 2021;79(7):4441-4465. doi: 10.1007/s00289-021-03729-3
  44. Ciocarlan A, Lupascu L, Aricu A, Dragalin I, Popescu V, Geană E, Ionete R, Vornicu N, Duliu O, Hristozova G, et al. Chemical composition and assessment of antimicrobial activity of lavender essential oil and some by-products. Plants. 2021;10(9):1829. doi: 10.3390/plants10091829
  45. Manjanna KM, Gouda BV, Tanusha AS, Ankita S, Anusha H, Arpita J. Formulation and evaluation of capsaicin transemulgel for the treatment of arthritis. J Drug Deliv Ther. 2025;15(1):73-83. doi: 10.22270/jddt.v15i1.6946
  46. Bayer IS. Fungal quorum sensing molecules as potential drugs in the treatment of chronic wounds and their delivery. Expert Opin Drug Deliv. 2025;22(2):277-296. doi: 10.1080/17425247.2025.2452303
  47. Sulaiman M , Hassan Y, Tok T, Noundou X. Synthesis, antibacterial activity and docking studies of benzyl alcohol derivatives. J Turk Chem Soc Sect A Chem. 2020;7(2):481-488. doi: 10.18596/jotcsa.692113
  48. Singh Y, Meher J, Raval K, Khan FA, Chaurasia M, Jain N, Chourasia MK. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017;252:28-49. doi: 10.1016/j.jconrel.2017.03.008
  49. Askarizadeh M, Esfandiari N, Honarvar B, Sajadian SA, Azdarpour A. Kinetic modeling to explain the release of medicine from drug delivery systems. ChemBioEng Rev. 2023;10(6):1006-1049. doi: 10.1002/cben.202300027
  50. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001;52(2):103-112. doi: 10.1016/S0939-6411(01)00166-7
  51. Setti C, Suarato G, Perotto G, Athanassiou A, Bayer IS. Investigation of in vitro hydrophilic and hydrophobic dual drug release from polymeric films produced by sodium alginate–MaterBi drying emulsions. Eur J Pharm Biopharm. 2018;130:71-82. doi: 10.1016/j.ejpb.2018.06.019
  52. Ignacio M, Chubynsky MV, Slater GW. Interpreting the Weibull fitting parameters for diffusion-controlled release data. Physica A. 2017;486:486-496. doi: 10.1016/j.physa.2017.05.033
  53. Cavanagh H, Wilkinson J. Biological activities of lavender essential oil. Phytother Res. 2002;16(4):301-308. doi: 10.1002/ptr.1103
  54. Peleg M. Advanced Quantitative Microbiology for Foods and Biosystems: Models for Predicting Growth and Inactivation. CRC Press; 2006. doi: 10.1201/9781420005370
  55. Geeraerd AH, Valdramidis VP, Van Impe JF. GInaFiT, a freeware tool to assess non-log-linear microbial survivor curves. Int J Food Microbiol. 2005;102(1):95-105. doi: 10.1016/j.ijfoodmicro.2004.11.038
  56. Whiting RC. Microbial modeling in foods. Crit Rev Food Sci Nutr. 1995;35(6):467-494. doi: 10.1080/10408399509527711
  57. Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, Burovski E, Peterson P, Weckesser W, Bright J, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17(3):261-272. doi: 10.1038/s41592-019-0686-2
  58. Wax RG, Lewis K, Salyers AA, Taber H. Bacterial Resistance to Antimicrobials. 2nd ed. CRC Press; 2007. doi: 10.1201/9781420008753
  59. Mouton JW, Vinks AA. Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics. Clin Pharmacokinet. 2005;44(2):201-210. doi: 10.2165/00003088-200544020-00005
  60. Choi SJ, Decker EA, Henson L, Popplewell LM, McClements DJ. Stability of citral in oil-in-water emulsions prepared with medium-chain triacylglycerols and triacetin. J Agric Food Chem. 2009;57(23):11349-11353. doi: 10.1021/jf902761h
  61. Givaudan SA. Flavour composition. Patent WO2015185553A1. Published December 10, 2015. https://patents.google.com/patent/WO2015185553A1/en
  62. T Hasegawa Co Ltd. Triacetin-mixed oil-in-water type emulsion composition. Patent JP2011045316A. Published March 10, 2011. https://patents.google.com/patent/JP2011045316A/en
Next article in this issue
Share
Back to top
Innovative Medicines & Omics, Electronic ISSN: 3060-8740 Print ISSN: 3060-8910, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept